Associated Papers
The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.
Wang LY et al.
Innovation (cambridge (mass.)), 2025
39991480 (PubMed )
Supplement: mmc5.xlsx › Sheet1
Effects of Germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on Mitotane Treatment in Adrenocortical Carcinoma: A Multicenter ENSAT Study.
Altieri B et al.
Cancers, 2020
Identification of Genetic Polymorphisms of CYP2W1 in the Three Main Chinese Ethnicities: Han, Tibetan, and Uighur.
Li Y et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2016
Novel single nucleotide polymorphisms (SNPs) of CYP2W1 gene in Chinese Uygur and Han populations.
Qi GZ et al.
Drug Metabolism and Pharmacokinetics, 2015
Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy.
Preissner SC et al.
Plos One, 2013
24340040 (PubMed )
Supplement: pone.0082562.s002.xlsx › CYP_SNP
Genetic polymorphisms and haplotype structures of the human CYP2W1 gene in a Japanese population.
Hanzawa Y et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2008
Select a paper to view details